What happened: A large review published in The Lancet analysed trials with over 120,000 participants comparing statins to placebos, finding statins to be much safer than earlier reports suggested.
Why it matters:
- Improves confidence in prescribing statins for cholesterol management
- Affects millions of patients considering or currently on statin therapy
MNN Take: This extensive analysis provides clearer evidence on the safety of statins, supporting their continued use in preventing cardiovascular disease.
Sources: BBC Health (Lifestyle)